CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
oleh: Claire M. Lucas, Laura J. Scott, Natasha Carmell, Alison K. Holcroft, Robert K. Hills, Alan K. Burnett, Richard E. Clark
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2018-05-01 |
Deskripsi
No description available for this item.